Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer

Breast Cancer Research and Treatment

Volumn 97, Issue 2, 2006, Pages 191-197

  Zalles, Carola M ^a   Kimler, Bruce F ^b   Simonsen, Marie ^b   Clark, Julie L ^b   Metheny, Trina ^b   Fabian, Carol J ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Epithelial; Risk assessment; RPFNA

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST AREOLA; BREAST BIOPSY; BREAST CANCER; BREAST CELL; BREAST DUCT; BREAST DUCT LAVAGE; CANCER CYTODIAGNOSIS; CANCER RISK; CANNULATION; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FOLLICULAR PHASE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LAVAGE; MASOOD INDEX SCORE; MENSTRUAL CYCLE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; BIOPSY, FINE-NEEDLE; BODY FLUIDS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; CYTODIAGNOSIS; EPITHELIAL CELLS; FEASIBILITY STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; NIPPLES; POSTMENOPAUSE; RISK FACTORS;

EID: 33646577443     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9111-x     Document Type: Article

References (36)

1. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55: 231-273, 1975
2. Boone CW, Bacus JW, Bacus JV, Steele VE, Kelloff GJ: Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials. Proc Soc Exp Biol Med 216: 151-165, 1997
3. Page DL, Dupont WD, Rogers LW, Rados MS: Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55: 2698-2708, 1985
4. Page DL, Dupont WD: Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326-1335, 1990
5. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW: Lobular neoplasia of the breast: higher risk for subsequent invasive cancer by more extensive disease. Hum Pathol 22: 1232-1239, 1991
6. Tavassoli FA, Norris HJ: A comparison of the results of long-term followup for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65: 518-529, 1990
7. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA: Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17: 14-21, 1993
8. Modan B, Lubin F, Alfandary E, Chetrit A, Papa M: Breast cancer following benign breast disease - a nationwide study. Breast Cancer Res Treat 46: 45, 1997abstract 164
9. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M: Breast cancer risk in women with abnormal cytology in nipple aspirates of beast fluid. J Natl Cancer Inst 93: 1791-1798, 2001
10. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS: Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 92: 1217-1227, 2000
11. Wrensch M, Petrakis NL, King EB, Lee MM, Miike R: Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. Am J Epidemiol 137: 829-833, 1993
12. Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, Goodson WH III, Hunt TK: Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 135: 130-141, 1992
13. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB: Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 93: 1624-1632, 2001
14. Gail MH, Briton LA, Byar DP, Corle DK, Green SB, Schair C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886, 1989
15. Mayo MS, Kimler BF, Fabian CJ: Evaluation of models for the prediction of breast cancer development in women at high risk of breast cancer. J Appl Res 1: 37-44, 2001
16. Morrow M, Vogel V, Ljung BM, O'Shaughnessy JA: Evaluation and management of the woman with an abnormal ductal lavage. J Am Coll Surg 194: 648-656, 2002
17. Vogel VG.: Atypia in the assessment of breast cancer risk: implications for management. Diagn Cytopathol 30: 151-157, 2004
18. Port ER, Montgomery LL, Heerdt AS, Borgen PI: Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 8: 580-585, 2001
19. Tchou J, Hou N, Rademaker A, Jordan VC, Morrow M: Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer 100: 1800-1806, 2004
20. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91: 1829-1846, 1999
21. Zalles C, Kimler BF, Kamel S, McKittrick R, Fabian CJ: Cytologic patterns in random aspirates from women at high and low risk for breast cancer. The Breast J 1: 343-349, 1995
22. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol 16: 295-311, 1997
23. Ljung BM, Chew KL, Moore DH II, King EB: Cytology of ductal lavage fluid of the breast. Diagn Cytopathol 30: 143-150, 2004
24. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB: Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 66: 1480-1487, 1990
25. Visvanathan K, Santor D, Ali S, Brewster A, Arnold A, Armstrong D, Helzlsouer K The reliability of ductal lavage in women at high risk for breast cancer. Abstracts of the American Society of Clinical Oncology 2005 Annual Meeting; Abstract 1001
26. Sharma P, Klemp JR, Simensen M, Welsko CM, Zalles CM, Kimler BF, Fabian CJ: Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Breast Cancer Res Treat 87: 59-64, 2004
27. Khan SA, Wiley EL, Rodriguez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke KB, Staradub VL, Wolfman J, Rademaker A, Ljung BM, Morrow M: Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst 96: 1510-1518, 2004
28. Cazzaniga M, Casadio C, Severi G, Chiapparini L, Galli A, Mora S, Veronesi U, Decensi A. Correlation between breast cancer risk, nipple discharge and atypical cells and KI-67 expression in ductal lavage specimens. American Association for Cancer Research Frontiers in Cancer Prevention Research 2003; p 33 (abstract A127)
29. Love SM, King BL: Ductal lavage in nipple aspirate fluid producing and non-producing ducts in healthy volunteers. Breast Cancer Res Treat 88(Suppl 1): S189-S190, 2004abstract 5019
30. Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW: Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 15: 39-51, 1990
31. King EB, Chew KL, Hom JD, Miike R, Wrensch MR, Petrakis NL.: Multiple sampling for increasing the diagnostic sensitivity of nipple aspirate fluid for atypical cytology. Acta Cytol 48: 813-817, 2004
32. Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H: Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76: 494-501, 1997
33. Francescatti DS, Kluskens L, Shah L: Ductal lavage using medically aseptic technique in women at high risk for breast cancer. Clin Breast Cancer 5: 299-302, 2004
34. Fabian CJ, Kimler BF, Elledge RM, Grizzle WE, Beenken SW, Ward JH: Models for early chemoprevention trials in breast cancer. Hematol Oncol Clin North Am 12: 993-1017, 1998
35. Fabian CJ, Kimler BF, Mayo MS, Grizzle WE, Masood, S, Ursin G: Clinical approaches to discovery and testing new breast cancer prevention drugs. In: Kelloff GJ, Hawk ET, Sigman CC (eds) Cancer Chemoprevention, Vol. 2; Strategies for Cancer Chemoprevention. Humana Press, Totowa, New Jersey, 2005, pp 213-238
36. Fabian CJ, Kimler BF, Brady DA, Mayo MS, Chang CHJ, Ferraro JA, Zalles CM, Stanton AL, Masood S, Grizzle WE, Boyd NF, Arneson DW, Johnson KA: A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 8: 3105-3117, 2002